Login
Join
Login
Join
Login
Join
Financings – Cont. from Vital Signs 12/1/23
more
We had several financings that didnt make the 12/1 edition of Vital Signs.

Biolexis Therapeutics – a company using AI for metabolic drug discovery, raised a $10M Series A. (American Fork, UT)

Aperiam Bio – a protein engineering company, raised a $9M Seed extension.(Brooklyn, NY)

Arrivo Bioventures – a drug developer, raised a $45M Series B.(Morrisville, NC)
Facebook
Twitter
LinkedIn
Categories
Archives

Recent Posts

In Memory of Charlie Emley, Jr.

Approximately 35 years ago I was visiting the home of my college buddy in Pasadena,…

Is The Venture Capital Party Over?

Mark Twain famously said “The reports of my death are greatly exaggerated.” Such is the…

Ai Juggernaut Palantir Enters Healthcare

Palantir is not exactly a household name, but the Peter Thiel founded company now based…

AngelMD is a large and growing healthcare innovation community connecting clinicians, startups, investors, Industry and other stakeholders.

Linkedin Facebook-f Youtube Twitter

About

Clinicians

Partners

Startups

Investors

AngelMD is a large and growing healthcare innovation community centered around clinician & startups with tools & education for both.

Linkedin Facebook-f Youtube Twitter

About

Clinicians

Partners

Startups

Investors

Top Cities / Regions - US

  • Seattle
  • Bay Area
  • Southern California
  • Salt Lake City
  • Denver / Boulder / Fort Collins
  • Chicago
  • Cleveland
  • Dallas
  • Austin
  • Houston
  • Atlanta
  • Florida
  • Boston
  • New York

Top International Regions

  • Canada
  • UK
  • Germany
  • Israel
  • MENA
  • India
  • Japan
  • Singapore
  • South Korea

Most Active Specialties

  • Dentistry
  • Orthopedics
  • Urology
  • Cardiology
  • ENT
  • Plastic Surgery
  • Gastroenterology
  • Oncology
  • Radiology
  • Ophthalmology
  • Pediatrics
  • Elder Care